Comments*

 
  • Translational Research & Medicine

  • Featured Event

    Green Buildings and Health: From the Lab to the Real World

    Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
    The New York Academy of Sciences

    Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.

  • Events 

    Saturday, January 28, 2017 | 11:00 AM - 4:00 PM

    Risky Business — The Future of Biopharmaceutical Innovation

    This event gives professionals from across the biopharmaceutical space — from scientists and industry executives, through healthcare providers and insurers to investors — a visceral understanding of how biopharma innovation dynamics are evolving, mimicking decision-making under pressure in a complex and changing environment.

    Monday, March 13, 2017 | 8:30 AM - 6:00 PM

    Targeting Tau in Alzheimer's Disease and Related Disorders

    Speakers: Michael G. Agadjanyan (The Institute for Molecular Medicine), Bernardino Ghetti, (Indiana University), Andreas Muhs (AC Immune SA), Michal Novák (AXON Neuroscience SE), Einar M. Sigurdsson (NYU School of Medicine), Henrik Zetterberg (University of Gothenburg, Sweden), and Khalid Iqbal (New York State Institute for Basic Research)

    This event will cover the translational potential of immunotherapy for tauopathies, reviewing the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic approach.

    March 15 - 16, 2017

    The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?

    Experience a public-facing dialogue exploring the nuanced ethical and scientific rationale behind randomized controlled clinical trials, accelerated alternatives, and the implications of these discussions on drug approval and patient interests.

    Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

    Gene Therapy for Rare Diseases

    Speakers: Brian Kaspar (Nationwide Children's Hospital), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida, Powell Gene Therapy Center), Maria Escolar (Children's Hospital of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and David Pearce (Sanford Research)

    Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in field, and identify ongoing obstacles on the path to wider use of this approach.

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

  • Past Events

    Thursday, November 3, 2016 | 9:00 AM - 5:00 PM

    Microbial Influences in Cardio–Metabolic Diseases

    Speakers: Henrik Bjørn Nielsen (Clinical-Microbiomics A/S), Martin J. Blaser (New York University Langone Medical Center), Patrice D. Cani (Universite Catholique de Louvain, LDRI), Rachel Carmody (Harvard University), Stanley L. Hazen (Cleveland Clinic), Gerald I. Shulman (Yale University School of Medicine), Marion Soto (Joslin Diabetes Center, Harvard Medical School), and Dan Winer (University of Toronto)

    The microbiome is emerging as an important regulator of health, and disease well beyond the digestive tract. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on metabolic disease.

    September 21 - 23, 2016

    13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms

    Featuring: Peder S. Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.

    Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)

    Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.

    Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.

  • Publications 

    Annals

    Special Issue: Musculoskeletal Repair and Regeneration

    Edited by Hui B. Sun (Albert Einstein College of Medicine)

    The papers in this Annals issue explore novel musculoskeletal repair and regeneration strategies that could be translated to clinical treatment of rotator cuff injuries, osteoarthritis, and other bone and cartilage diseases.

    Volume 1383

    Annals

    Special Issue: The 13th OESO World Conference: The Esophagiome II

    Edited by Robert Giuli (OESO Foundation) and Hans Gregersen (Prince of Wales Hospital, Hong Kong)

    This Annals issue is the second of two issues featuring review articles on topics related to esophageal function, dysfunction, and disease presented at the 13th OESO World Conference, with a focus on the Esophagiome.

    Volume 1381

    Annals

    Special Issue: The 13th OESO World Conference: The Esophagiome I

    Edited by Robert Giuli (OESO Foundation) and Hans Gregersen (Prince of Wales Hospital, Hong Kong)

    This Annals issue is the first of two issues featuring review articles on topics related to esophageal function, dysfunction, and disease presented at the 13th OESO World Conference, with a focus on the Esophagiome.

    Volume 1380

    Annals

    Special Issue: Countermeasures Against Chemical Threats II

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Discussions of various countermeasures to chemical threats.